Fee-fi-fo future.
AI in the fast lane.
AstraZeneca strategy.
View in browser
Hi there,
Here are this week's top research briefs.
State of Venture Q1’24 Report
VC dealmaking slides to a 7-year low, while several blockbuster deals drive a modest rebound in funding.
The future of big tech in 10 charts
Big tech has grown revenue at a breakneck pace for years. But their size — plus intensifying competition and the generative AI boom — is pressuring tech giants to find new growth avenues.
Generative AI predictions for 2024
Nvidia’s frenemies. AI girlfriends. Pocket-sized LLMs. Here are our 18 genAI predictions for 2024.
How AI is reshaping the auto industry: A look at 15 high-momentum technologies across the automotive value chain
In this report, we explore an emerging set of technologies impacting automotive R&D, manufacturing, sales, vehicle use, and the aftermarket.
Y Combinator’s recent generative AI bets privilege productivity and LLMOps
We analyzed Y Combinator’s latest cohort to discern the investor's priorities in generative AI.
Analyzing AstraZeneca’s growth strategy: How the pharma giant is streamlining drug development using AI and real-world data
We mined AstraZeneca’s partnerships, investments, and acquisitions to discern the company's strategic priorities.
Have a great weekend.
I love you.
Anand
@asanwal
P.S. We're hiring. Check out our open positions here and let us know what you got.
CB Insights' emerging technology insights platform provides all the
analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech.
Was this email forwarded to you? Sign up here
Copyright © 2024 CB Insights, All rights reserved.
498 7th Avenue, NY, CB Insights, New York,10018
About Us | Update Preferences | Research | Newsletter